AQS.V - Aequus Pharmaceuticals Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Currency in CAD

Valuation Measures

Market Cap (intraday) 510.46M
Enterprise Value 310.24M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.84
Price/Book (mrq)65.00
Enterprise Value/Revenue 37.67
Enterprise Value/EBITDA 6-4.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.64
52-Week Change 3-36.36%
S&P500 52-Week Change 326.46%
52 Week High 30.2450
52 Week Low 30.0900
50-Day Moving Average 30.1239
200-Day Moving Average 30.1459

Share Statistics

Avg Vol (3 month) 389.66k
Avg Vol (10 day) 3124.42k
Shares Outstanding 580.44M
Float 73.31M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Dec. 30, 2019) 494.81k
Short Ratio (Dec. 30, 2019) 40.38
Short % of Float (Dec. 30, 2019) 4N/A
Short % of Shares Outstanding (Dec. 30, 2019) 40.12%
Shares Short (prior month Nov. 28, 2019) 483.09k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2018
Most Recent Quarter (mrq)Sep. 29, 2019

Profitability

Profit Margin -205.21%
Operating Margin (ttm)-196.27%

Management Effectiveness

Return on Assets (ttm)-60.54%
Return on Equity (ttm)-225.37%

Income Statement

Revenue (ttm)1.33M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-11.70%
Gross Profit (ttm)1.41M
EBITDA -2.45M
Net Income Avi to Common (ttm)-2.74M
Diluted EPS (ttm)-0.0340
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.05M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.04M
Total Debt/Equity (mrq)1,096.63
Current Ratio (mrq)2.77
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.91M
Levered Free Cash Flow (ttm)-760.29k